| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5623648 | Alzheimer's & Dementia | 2017 | 5 Pages |
Abstract
Plasma concentrations of free Aβ could not predict the development of clinical AD, and Aβ concentrations did not change in the years preceding AD diagnosis in this sample. These results indicate that free plasma Aβ is not a useful biomarker for the identification of individuals at risk of developing clinical AD.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Hugo Lövheim, Fredrik Elgh, Anders Johansson, Henrik Zetterberg, Kaj Blennow, Göran Hallmans, Sture Eriksson,